Latest News & Features
Biotechnology
Biotech company Shire has revealed plans to sell its oncology business for $2.4 billion to France-based Servier. 17 April 2018
Americas
Courts have not always been able to appreciate the complexities around antibody patents, causing problems for innovation and investment, says Eli Lilly patent counsel Duane Marks in an interview with LSIPR. 17 April 2018
Americas
The founder of a Canadian online pharmacy has been sentenced to house arrest and his company fined $34 million for importing counterfeit drugs into the US. 16 April 2018
Americas
Vanda Pharmaceuticals, a biopharmaceutical company based in Washington, DC, secured a win late last week when the US Court of Appeals for the Federal Circuit found a patent covering its schizophrenia drug to be patentable. 16 April 2018
Big Pharma
Ireland-based Cosmo Pharmaceuticals has lost a legal battle against Valeant Pharmaceuticals, costing it $3 million. 16 April 2018
Americas
Orchard Therapeutics has acquired GSK’s gene therapy portfolio, in an agreement intended to advance Orchard’s work in the field of rare diseases and allow GSK to focus on oncology. 13 April 2018
article
Variable sequence IP is fertile ground for potential validity challenges based on prior art or lack of enablement, as Ellen Sherin of GQ Life Sciences reports. 12 April 2018
Asia
Japan-based Chugai Pharmaceuticals has announced it has withdrawn its patent infringement claim against generic anti-cancer business Nippon Kayaku. 12 April 2018
Asia
The ChinaBio Partnering Forum, which will be held in Suzhou from April 25 to 26, is celebrating its tenth anniversary and is expected to attract pharma and biotech companies from around the world. 12 April 2018
Americas
The US Federal Trade Commission is to appeal against a court’s decision to dismiss its competition complaint against Shire ViroPharma, a subsidiary of pharmaceutical company Shire. 12 April 2018